Patent details

Basic Information

Publication number:

EP2970372

PCT Application Number:

US2014027039

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147701510

PCT Publication Number:

WO2014152177

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED T LYMPHOCYTES

French Title of Invention:

LYMPHOCYTES T MODIFIÉS

German Title of Invention:

MODIFIZIERTE T-LYMPHOZYTEN

SPC Number:

Dates

Filing date:

14/03/2014

Grant date:

30/09/2020

EP Publication Date:

20/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/09/2020

EP B1 Publication Date:

30/09/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/03/2021

Expiration date:

14/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/09/2020

 

 

Name:

Celgene Corporation

Address:

86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:

LI, Tianjian

Address:

United States (US)

2

Name:

LIANG, Bitao

Address:

United States (US)

3

Name:

ABBOT, Stewart

Address:

United States (US)

Priority

Priority Number:

201361794294 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/17; A61K 39/395; A61P 35/00; C07K 14/725; C07K 16/28; C12N 5/0783; A61K 35/17;

Publication

European Patent Bulletin

1

Issue number:

202040

Publication date:

30/09/2020

Description:

Grant (B1)

2

Issue number:

202045

Publication date:

04/11/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages